Biliary atresia is a rare but serious condition in which a newborn's bile ducts become inflamed and blocked, leading to progressive liver damage and ultimately liver failure if untreated. It is one of the most common reasons for pediatric liver transplantation. Early detection and medical intervention are critical to improve outcomes and quality of life for affected infants. The condition typically presents within the first few weeks of life, with symptoms such as jaundice (yellowing of the skin and eyes), dark urine, pale stools, and poor weight gain. Because these symptoms can be mistaken for more common neonatal issues, raising awareness among parents and healthcare providers is essential for timely diagnosis. Diagnosis involves blood tests, imaging studies, and sometimes liver biopsy to confirm bile duct obstruction. The primary treatment is the Kasai procedure, a surgery that restores bile flow and can delay or prevent the need for liver transplantation. However, despite the best care, some children progress to liver failure and may require transplant. Families face significant emotional and physical challenges supporting a baby with biliary atresia. Access to specialized medical care, support groups, and education about liver health help navigate this difficult journey. Increasing public knowledge about biliary atresia helps promote early screening, timely treatment, and research into better therapies. With ongoing advances, there is hope for improving survival and quality of life for babies born with this condition. Support from the medical community and advocacy efforts remains vital in battling biliary atresia's impact on families worldwide.